IKON Group Investments — Global Holdings Company

IKON Market Brief: Abridge expands AI decision support to more clinicians in bid to become healthcare's copilot

Posted by:

|

On:

|

Since April, more than 300 enterprise health systems have adopted Abridge’s artificial intelligence-based decision support solution, and the company is now making the tool available to every clinician at its partner health systems.

Source: www.fiercehealthcare.com

IKON Portfolio Context

Our healthcare vertical includes Renew Republic Health (precision medicine, TRT, peptide therapy) and Renew Lab Group (pharmaceutical testing), both headquartered in Houston, Texas.

Posted by

in